PAUL B WATKINS
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology CHAPEL HILL, NC NPI 1386705366
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NC Mirum Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$803,068.78
- Category: General Payments
- Program years: PY2018–2024
- Record count: 258
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $91,741.14 across 25 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $90,991.14 | 23 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $750.00 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | $35,100.00 | 1 |
| GENZYME CORPORATION | $12,401.64 | 3 |
| PFIZER INC. | $9,100.00 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $6,337.50 | 4 |
| Amgen Inc. | $4,044.00 | 1 |
| Biogen, Inc. | $3,990.50 | 2 |
| Janssen Research & Development, LLC | $3,900.00 | 2 |
| Gilead Sciences, Inc. | $3,867.50 | 2 |
| Sarepta Therapeutics, Inc. | $3,575.00 | 1 |
| F. Hoffmann-La Roche AG | $2,817.50 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,762.50 | 1 |
| Sage Therapeutics, Inc. | $1,625.00 | 1 |
| JAZZ PHARMACEUTICALS INC. | $1,610.00 | 2 |
| Merck Sharp & Dohme Corporation | $610.00 | 1 |
By program year
Records — PY2024 (25)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.